Thymic carcinoma diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
Shyam Patel (talk | contribs) Created page with "__NOTOC__ {{Thymic carcinoma}} {{CMG}} {{shyam}}; {{AE}}{{PSD}} ==Overview== The staging of thymic carcinoma is based on the Masoka and GETT staging system.<ref name="pmid804..." |
Shyam Patel (talk | contribs) |
||
Line 7: | Line 7: | ||
==Diagnostic study of choice== | ==Diagnostic study of choice== | ||
The diagnostic study of choice for thymic carcinoma is tissue biopsy.<ref name="pmid30714349">{{cite journal| author=Akiyama T, Miyamoto Y, Nomoto D, Kiyozumi Y, Eto K, Hiyoshi Y et al.| title=Laparoscopic dissection for pelvic lymph node recurrence of thymic carcinoma: A case report. | journal=Asian J Endosc Surg | year= 2019 | volume= | issue= | pages= | pmid=30714349 | doi=10.1111/ases.12688 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30714349 }} </ref> | The diagnostic study of choice for thymic carcinoma is tissue biopsy.<ref name="pmid30714349">{{cite journal| author=Akiyama T, Miyamoto Y, Nomoto D, Kiyozumi Y, Eto K, Hiyoshi Y et al.| title=Laparoscopic dissection for pelvic lymph node recurrence of thymic carcinoma: A case report. | journal=Asian J Endosc Surg | year= 2019 | volume= | issue= | pages= | pmid=30714349 | doi=10.1111/ases.12688 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30714349 }} </ref> | ||
Revision as of 04:49, 10 February 2019
Thymic Carcinoma Microchapters |
Diagnosis |
---|
Case Studies |
Thymic carcinoma diagnostic study of choice On the Web |
American Roentgen Ray Society Images of Thymic carcinoma diagnostic study of choice |
Risk calculators and risk factors for Thymic carcinoma diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [3]
Overview
The staging of thymic carcinoma is based on the Masoka and GETT staging system.[1]
Diagnostic study of choice
The diagnostic study of choice for thymic carcinoma is tissue biopsy.[2]
References
- ↑ Masaoka A, Yamakawa Y, Niwa H, Fukai I, Saito Y, Tokudome S; et al. (1994). "Thymectomy and malignancy". Eur J Cardiothorac Surg. 8 (5): 251–3. PMID 8043287.
- ↑ Akiyama T, Miyamoto Y, Nomoto D, Kiyozumi Y, Eto K, Hiyoshi Y; et al. (2019). "Laparoscopic dissection for pelvic lymph node recurrence of thymic carcinoma: A case report". Asian J Endosc Surg. doi:10.1111/ases.12688. PMID 30714349.